Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity-Reference-Cited by-同舟云学术

Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity

Published:2005-11 Issue:5 Volume:150 Page:1106.e1-1106.e6
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Harris Kevin M.,Aeppli Dorothee M.,Carey Charles F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Progression of mitral regurgitation;Enriquez-Sarano;J Am Coll Cardiol,1999

2. Guidelines for the Management of Patients With Valvular Heart Disease

3. Effects of afterload reduction on vena contracta width in mitral regurgitation;Kizilbash;J Am Coll Cardiol,1998

4. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves;Levine;J Am Coll Cardiol,1996

5. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation;Wisenbaugh;J Heart Valve Dis,1994

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Impact of ACE-I/ARB for Conservatively Treated Patients with Moderate to Severe Mitral Regurgitation: A Single Center Observational Study;Journal of Cardiovascular Development and Disease;2023-04-18

2. A Retrospective Study on Drug and Dietary Patterns in Patients With Severe Rheumatic Valvular Heart Disease in Eastern India;Cureus;2023-04-10

3. Comparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease;Cardiovascular Revascularization Medicine;2023-02

4. A Case of Complex Pulmonary Hypertension: the Importance of Diagnostic Investigation;Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine;2022-01

5. Perioperative Management of Valvular Heart Disease;Perioperative Medicine;2022